Health-related quality of life from a phase 4 global clinical study to evaluate discontinuation and rechallenge of pexidartinib in patients with tenosynovial giant cell tumor (TGCT) previously treated with pexidartinib Meeting Abstract
| Authors: | Desai, J.; Wagner, A. J.; Garcia, I. C.; Cesari, M.; Gordon, M.; Lin, C. C.; Papai, Z.; Ryan, C. W.; Tap, W. D.; Trent, J. C.; Gelderblom, H.; Grimison, P.; Pousa, A. L.; Van, B. A. T.; Dai, D.; Rubinacci, M.; Tecson, K.; Wooddell, M.; Stacchiotti, S. |
| Abstract Title: | Health-related quality of life from a phase 4 global clinical study to evaluate discontinuation and rechallenge of pexidartinib in patients with tenosynovial giant cell tumor (TGCT) previously treated with pexidartinib |
| Meeting Title: | ISPOR 2024 |
| Journal Title: | Value in Health |
| Volume: | 27 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2024 May 5-8 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 1098-3015 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2024-06-01 |
| Start Page: | S20 |
| Language: | English |
| ACCESSION: | WOS:001277006600084 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jval.2024.03.111 |
| Notes: | Meeting Abstract: CO22 -- Source: Wos |
